Building on a deadde of CDx experience

Discover the next chapter in the Oncomine Dx CDx journey. For more than a decade, Oncomine Dx CDx has helped advance precision oncology by supporting next-generation sequencing, companion diagnostic testing, and access to relevant genomic insights for cancer care. From its first-of-its-kind multi-NGS CDx milestone to continued global expansion, Oncomine Dx CDx has played an important role in helping laboratories and clinical teams connect patients with actionable biomarker information. This video highlights the evolution of Oncomine Dx CDx and introduces the new Oncomine Dx Express Test, designed to enable faster access to relevant gene content and support more efficient oncology testing workflows. Learn how Thermo Fisher Scientific continues to support precision oncology through innovative molecular diagnostic solutions, scalable NGS technology, and companion diagnostic development for today’s rapidly evolving cancer treatment landscape. Topics covered: Oncomine Dx CDx, Oncomine Dx Express Test, companion diagnostics, next-generation sequencing, NGS, oncology testing, biomarker testing, genomic profiling, precision oncology, molecular diagnostics, targeted therapy, cancer diagnostics, and global access to CDx solutions. Learn more about Thermo Fisher Scientific oncology solutions and Oncomine Dx CDx.